Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
Asset disposition
Acq. announced
Director departure
MEI Pharma, Inc. (MEIP) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 8-K Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Amendments to Articles of I...
Docs: "Certificate of Designation of Series A Junior Participating Preferred Stock of MEI Pharma, Inc",
"Rights Agreement, by and between MEI Pharma, Inc. and Computershare, Inc., as rights agent",
"MEI Pharma Adopts Limited-Duration Stockholder Rights Plan"
09/26/2023 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"MEI Pharma Reports Fiscal Year 2023 Results and Operational Highlights"
07/27/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Separation and Release Agreement between the Company and Brian Drazba",
"Separation and Release Agreement between the Company and Brian Drazba"
07/24/2023 8-K Quarterly results
07/19/2023 8-K Quarterly results
07/18/2023 8-K Quarterly results
07/17/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "MEI Pharma Encourages Shareholders to Vote FOR the Infinity Transaction SAN DIEGO, July 17, 2023 - MEI Pharma, Inc. today mailed the following letter to shareholders, encouraging them to vote FOR the pending transaction with Infinity Pharmaceuticals, Inc. in connection with the Company's special meeting on July 23, 2023, at 10:00 a.m. Eastern Time: Dear Fellow MEI Shareholders, We have extended the opportunity for shareholders to vote FOR our pending transaction with Infinity Pharmaceuticals, Inc. If you haven't voted yet, you can still do so today. Through this transaction, we are creating a combined company that is well capitalized and positioned to advance a diversified pipeline of three clinical-stage development programs. On a recent webcast, Dr. Ezra Cohen, a leading medical oncolo..."
07/13/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"MEI Pharma Postpones Special Meeting of Shareholders"
07/07/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"MEI Pharma Reminds Shareholders to Vote FOR the Merger with Infinity Pharmaceuticals"
07/05/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"MEI Pharma Highlights Recommendation by Leading Independent Proxy Advisory Firm ISS to Vote “FOR” Pending Transaction with Infinity Pharmaceuticals",
"Post Card mailed to shareholders of the Company"
06/29/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "MEI Pharma Mails Letter to Shareholders Reiterating Value Creating Potential of Proposed Transaction with Infinity Pharmaceuticals"
06/02/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "CEO Employment Agreement between the Company and David Urso",
"MEI Pharma Announces Planned Departure of CEO Daniel P. Gold, Ph.D. and Appointment of David M. Urso as Successor"
06/01/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "MEI Pharma Board of Directors Rejects Unsolicited Proposal"
05/11/2023 8-K Quarterly results
Docs: "MEI Pharma Reports Third Quarter Fiscal Year 2023 Results and Operational Highlights"
04/14/2023 8-K Quarterly results
03/13/2023 8-K Regulation FD Disclosure  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
02/23/2023 8-K Acquisition/merger/asset purchase announced
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"AGREEMENT AND PLAN OF MERGER",
"Fifth Amended and Restated Bylaws of MEI Pharma, Inc., effective as of February 23, 2023",
"MEI Pharma and Infinity Pharmaceuticals Announce Definitive Merger Agreement to Advance Three Promising Clinical Oncology Candidates",
"Investor Presentation of Infinity Pharmaceuticals, Inc. and MEI Pharma, Inc."
02/09/2023 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"MEI Pharma Reports Second Quarter Fiscal Year 2023 Results and Operational Highlights"
01/06/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
12/08/2022 8-K Quarterly results
11/14/2022 8-K Quarterly results
10/07/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
09/15/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
07/07/2022 8-K Quarterly results
05/23/2022 8-K Quarterly results
05/13/2022 8-K Quarterly results
12/23/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Letter Agreement between Brian G. Drazba and MEI Pharma, Inc."
12/17/2021 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Fourth Amended and Restated By-Laws of MEI Pharma, Inc. (effective as of December 16, 2021)"
12/06/2021 8-K Quarterly results
11/30/2021 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"MEI Pharma and Kyowa Kirin Announce Data From the Ongoing Global Phase 2 TIDAL Study Evaluating Zandelisib as a Single Agent in Patients with Relapsed or Refractory Follicular Lymphoma"
11/23/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "MEI Pharma Appoints Biotechnology Executive Sujay Kango to its Board of Directors"
08/05/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Transition and Retirement Agreement between Brian G. Drazba and MEI Pharma, Inc.",
"MEI Pharma Announces Planned Chief Financial Officer Transition"
06/11/2021 8-K Quarterly results
04/30/2021 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy